Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review

Introduction Autologous cell therapy products are patient-specific therapies that use cells harvested from a single patient to treat that same patient. Living cell constructs cannot be terminally sterilized and typically have a shelf life measured in days rather than months. Final product release te...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter and WEBINAR UPDATES

We will not sell or give your information to a third party. See our Privacy Policy